These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

522 related articles for article (PubMed ID: 25905982)

  • 1. Differential Effects of Calcineurin and Mammalian Target of Rapamycin Inhibitors on Alloreactive Th1, Th17, and Regulatory T Cells.
    Gallon L; Traitanon O; Yu Y; Shi B; Leventhal JR; Miller J; Mas V; L X; Mathew JM
    Transplantation; 2015 Sep; 99(9):1774-84. PubMed ID: 25905982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential regulation of Tregs and Th17/Th1 cells by a sirolimus-based regimen might be dependent on STAT-signaling in renal transplant recipients.
    Li Y; Shi Y; Liao Y; Yan L; Zhang Q; Wang L
    Int Immunopharmacol; 2015 Sep; 28(1):435-43. PubMed ID: 26186486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allospecific regulatory effects of sirolimus and tacrolimus in the human mixed lymphocyte reaction.
    Levitsky J; Gallon L; Miller J; Tambur AR; Leventhal J; Flaa C; Huang X; Sarraj B; Wang E; Mathew JM
    Transplantation; 2011 Jan; 91(2):199-206. PubMed ID: 21239962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of mammalian target of rapamycin inhibition on T helper type 17 and regulatory T cell differentiation in vitro and in vivo in kidney transplant recipients.
    Kim KW; Chung BH; Kim BM; Cho ML; Yang CW
    Immunology; 2015 Jan; 144(1):68-78. PubMed ID: 24974886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sirolimus vs mycophenolate moftile in Tacrolimus based therapy following induction with Antithymocyte globulin promotes regulatory T cell expansion and inhibits RORγt and T-bet expression in kidney transplantation.
    Jamali S; Sarafnejad A; Ahmadpoor P; Nafar M; Karimi M; Eteghadi A; Yekaninejad MS; Amirzargar AA
    Hum Immunol; 2019 Sep; 80(9):739-747. PubMed ID: 30597187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interplay between mTOR and STAT5 signaling modulates the balance between regulatory and effective T cells.
    Shan J; Feng L; Sun G; Chen P; Zhou Y; Xia M; Li H; Li Y
    Immunobiology; 2015 Apr; 220(4):510-7. PubMed ID: 25468562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of T Helper Cell Differentiation by Tacrolimus or Sirolimus Results in Reduced B-Cell Activation: Effects on T Follicular Helper Cells.
    Kraaijeveld R; Li Y; Yan L; de Leur K; Dieterich M; Peeters AMA; Wang L; Shi Y; Baan CC
    Transplant Proc; 2019 Dec; 51(10):3463-3473. PubMed ID: 31733794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential Effects of Tacrolimus versus Sirolimus on the Proliferation, Activation and Differentiation of Human B Cells.
    Traitanon O; Mathew JM; La Monica G; Xu L; Mas V; Gallon L
    PLoS One; 2015; 10(6):e0129658. PubMed ID: 26087255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-12 inhibits the TGF-β-dependent T cell developmental programs and skews the TGF-β-induced differentiation into a Th1-like direction.
    Prochazkova J; Pokorna K; Holan V
    Immunobiology; 2012 Jan; 217(1):74-82. PubMed ID: 21903294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacodynamic monitoring of mammalian target of rapamycin inhibition by phosphoflow cytometric determination of p70S6 kinase activity.
    Hoerning A; Wilde B; Wang J; Tebbe B; Jing L; Wang X; Jian F; Zhu J; Dolff S; Kribben A; Hoyer PF; Witzke O
    Transplantation; 2015 Jan; 99(1):210-9. PubMed ID: 25099702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD45RA Distinguishes CD4+CD25+CD127-/low TSDR Demethylated Regulatory T Cell Subpopulations With Differential Stability and Susceptibility to Tacrolimus-Mediated Inhibition of Suppression.
    Arroyo Hornero R; Betts GJ; Sawitzki B; Vogt K; Harden PN; Wood KJ
    Transplantation; 2017 Feb; 101(2):302-309. PubMed ID: 28118317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunosuppressive effects of DTCM-G, a novel inhibitor of the mTOR downstream signaling pathway.
    Shibasaki S; Yamashita K; Goto R; Wakayama K; Tsunetoshi Y; Zaitsu M; Igarashi R; Haga S; Ozaki M; Umezawa K; Todo S
    Transplantation; 2013 Feb; 95(4):542-50. PubMed ID: 23269193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. mTOR Inhibition Attenuates Dextran Sulfate Sodium-Induced Colitis by Suppressing T Cell Proliferation and Balancing TH1/TH17/Treg Profile.
    Hu S; Chen M; Wang Y; Wang Z; Pei Y; Fan R; Liu X; Wang L; Zhou J; Zheng S; Zhang T; Lin Y; Zhang M; Tao R; Zhong J
    PLoS One; 2016; 11(4):e0154564. PubMed ID: 27128484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment with mTOR inhibitors after liver transplantation enables a sustained increase in regulatory T-cells while preserving their suppressive capacity.
    Ghazal K; Stenard F; Dahlqvist G; Barjon C; Aoudjehane L; Scatton O; Conti F
    Clin Res Hepatol Gastroenterol; 2018 Jun; 42(3):237-244. PubMed ID: 29175009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Schisandrin B inhibits Th1/Th17 differentiation and promotes regulatory T cell expansion in mouse lymphocytes.
    Chen Z; Guo M; Song G; Gao J; Zhang Y; Jing Z; Liu T; Dong C
    Int Immunopharmacol; 2016 Jun; 35():257-264. PubMed ID: 27085037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amniotic membrane mesenchymal cells-derived factors skew T cell polarization toward Treg and downregulate Th1 and Th17 cells subsets.
    Pianta S; Bonassi Signoroni P; Muradore I; Rodrigues MF; Rossi D; Silini A; Parolini O
    Stem Cell Rev Rep; 2015 Jun; 11(3):394-407. PubMed ID: 25348066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapamycin Combined with Immature Dendritic Cells Attenuates Obliterative Bronchiolitis in Trachea Allograft Rats by Regulating the Balance of Regulatory and Effector T Cells.
    Dong M; Wang X; Liu J; Zhao YX; Chen XL; Li KQ; Li G
    Int Arch Allergy Immunol; 2015; 167(3):177-85. PubMed ID: 26302996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammation-driven reprogramming of CD4+ Foxp3+ regulatory T cells into pathogenic Th1/Th17 T effectors is abrogated by mTOR inhibition in vivo.
    Yurchenko E; Shio MT; Huang TC; Da Silva Martins M; Szyf M; Levings MK; Olivier M; Piccirillo CA
    PLoS One; 2012; 7(4):e35572. PubMed ID: 22545118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relative impact of CD4+CD25+ regulatory T cells and tacrolimus on inhibition of T-cell proliferation in patients with atopic dermatitis.
    Vukmanovic-Stejic M; McQuaid A; Birch KE; Reed JR; Macgregor C; Rustin MH; Akbar AN
    Br J Dermatol; 2005 Oct; 153(4):750-7. PubMed ID: 16181456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Focus on mTOR inhibitors and tacrolimus in renal transplantation: pharmacokinetics, exposure-response relationships, and clinical outcomes.
    Shihab F; Christians U; Smith L; Wellen JR; Kaplan B
    Transpl Immunol; 2014 Jun; 31(1):22-32. PubMed ID: 24861504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.